Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 11/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | DAGLB | Q8NCG7 | 2/20 | 0.40 |
| ▸ | DAGLA | Q9Y4D2 | 2/20 | 0.40 |
| ▸ | SMYD3 | Q9H7B4 | 2/20 | 0.39 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.38 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17431025 | 0.89 | AGER (0.46) | OPRM1TMEM97SIGMAR1 | |
| SCHEMBL16635727 | 0.82 | RIPK1 (0.38) | C5AR1 | |
| SCHEMBL15648591 | 0.81 | RAB9A (0.40) | MEN1KMT2AOPRM1ALDH1A1TMEM97 | |
| SCHEMBL14798629 | 0.79 | GPBAR1 (0.40) | MEN1KMT2A | |
| SCHEMBL28383255 | 0.79 | DCUN1D1 (0.42) | ALDH1A1 | |
| SCHEMBL29269873 | 0.79 | PIK3CD (0.38) | SMYD3 | |
| SCHEMBL13731461 | 0.79 | SLC6A2 (0.43) | MEN1KMT2AOPRM1ALDH1A1C5AR1 | |
| SCHEMBL13723227 | 0.79 | SLC6A2 (0.44) | OPRM1ALDH1A1 | |
| SCHEMBL29368410 | 0.79 | SLC6A2 (0.43) | MEN1KMT2AOPRM1ALDH1A1C5AR1 | |
| SCHEMBL25994113 | 0.79 | RAB9A (0.38) | OPRM1PKMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10626109-B2 | N-hetaryl(thio)carbonyl-2-(benzocycloalken-1-yl)cyclamines and their use as fungicides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-04-21 | — | — | US | disclosed |
| EP-3055296-B1 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1-YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2018-11-28 | — | — | EP | disclosed |
| US-20160244433-A1 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1-YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-08-25 | — | — | US | disclosed |
| EP-3055296-A1 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1 -YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | Bayer CropScience Aktiengesellschaft (DE) | 2016-08-17 | — | — | EP | disclosed |
| CN-105636947-A | N-hetaryl(thio)carbonyl-2-(benzocycloalken-1 -yl)cyclamines and their use as fungicides | BAYER CROPSCIENCE AG | 2016-06-01 | — | — | CN | disclosed |
| WO-2015052160-A9 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1 -YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2015-09-17 | — | — | WO | disclosed |
| WO-2015052160-A1 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1 -YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2015-04-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10626109-B2 | N-hetaryl(thio)carbonyl-2-(benzocycloalken-1-yl)cyclamines and their use as fungicides | CBR1, CBR3, CYP4Z1 | MEN1 2885/4885KMT2A 2029/4885OPRM1 2111/4885 |
| US-20160244433-A1 | N-HETARYL(THIO)CARBONYL-2-(BENZOCYCLOALKEN-1-YL)CYCLAMINES AND THEIR USE AS FUNGICIDES | CBR1, CBR3, CYP4Z1 | MEN1 2885/4885KMT2A 2029/4885OPRM1 2111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.